食管癌组织中hMSH2基因的表达

南方医科大学学报 ›› 2004, Vol. 24 ›› Issue (06): 662-664,669.

食管癌组织中hMSH2基因的表达

张功员¹, 刘秋亮², 马春晓², 乐晓平¹, 葛秀峰¹, 丁一¹, 张钦宪¹

1. 郑州大学分子医学重点实验室, 河南, 郑州, 450052;
2. 郑州大学第一附属医院小儿外科, 河南, 郑州, 450052

出版日期:2004-06-20 发布日期:2004-06-20
基金资助:
收稿日期:2004-1-22。
基金项目:河南省科技攻关基金(324410033)
作者简介:张功员(1965- ),男,郑州大学医学院硕士研究生,电话:0371-6940330,E-mail:zgy@zzu.edu.cn.

Expression of hMSH2 gene in esophageal cancer

ZHANG Gong-yuan¹, LIU Qiu-liang², MA Chun-xiao², LE Xiao-ping¹, GE Xiu-feng¹, DING Yi¹, ZHANG Qin-xian¹

1. 郑州大学分子医学重点实验室, 河南, 郑州, 450052;
2. 郑州大学第一附属医院小儿外科, 河南, 郑州, 450052

Online:2004-06-20 Published:2004-06-20

摘要/Abstract

摘要： 目的观察食管癌组织中DNA错配修复基因hMSH2的表达。方法 32例食管癌患者术前均未接受放疗、化疗等其他治疗,标本切除后0.5 h内在癌灶、癌旁及正常残端各取1 cm×1 cm×1 cm大小的组织块,应用原位杂交法检测hMSH2。结果食管癌组织中hMSH2的阳性表达率为46.88%、癌旁为53.12%、正常组织为84.38%。与正常食管组织相比,食管癌和癌旁组织中hMSH2的阳性表达率均明显降低(P<0.05)。hMSH2阳性表达率与食管癌患者年龄及性别,肿瘤大小、肿瘤位置、病理类型、组织学分级、淋巴结转移、浸润深度等均无明显相关性(P>0.05)。结论 hMSH2缺失是食管癌发生的早期事件。

Abstract: Objective To observe the expression of DNA mismatch repair gene hMSH2 mRNA in esophageal cancer tissues. Methods This study included 32 esophageal cancer patients who received no previous radiotherapy, chemotherapy or other treatments. Within 30 min following surgical removal of the tumor tissues, specimens of the tumor, the tissue adjacent to the tumor and normal tissue at the esophageal stump (1 cm×1 cm×1 cm in size for each specimen) were obtained for examining hMSH2 expression with hMSH2 ISH detection kit. Results The positivity rate of hMSH2 was 46.88% in the esophageal can-cer tissues, 53.12% in the adjacent tissues, and 84.38% in normal tissues at the esophageal stump, showing significant differ-ence of the former two tissues from the normal tissue (P<0.05). No significant correlation was noted between the positivity rate of hMSH2 and such factors as the patients’ age, sex, tumor size, tumor location, pathological type, histological grade, lym-phatic metastasis or degree of tumor invasion (P>0.05). Conclusion The deletion of hMSH2 is an early event in the develop-ment of esophageal cancer.

中图分类号:

R735.1

张功员¹, 刘秋亮², 马春晓², 乐晓平¹, 葛秀峰¹, 丁一¹, 张钦宪¹. 食管癌组织中hMSH2基因的表达[J]. 南方医科大学学报, 2004, 24(06): 662-664,669.

ZHANG Gong-yuan¹, LIU Qiu-liang², MA Chun-xiao², LE Xiao-ping¹, GE Xiu-feng¹, DING Yi¹, ZHANG Qin-xian¹. Expression of hMSH2 gene in esophageal cancer[J]. Journal of Southern Medical University, 2004, 24(06): 662-664,669.

参考文献

[1] Wood RD,Mitchell M,SgourosJ,et al.Human DNA repair gene[J].Science,2001,29(5507):1284-94.
[2] Yu Z,ChenJ,Ford BN,et al.Human DNA repair systems:a review[J].Environ Mol Mutagen,1999,33(1):3-20.
[3] Leach FS,Nicolaides NC,Papadopoulous N,et al.Mutations of a mutS homolog in HNPCC[J].Cell,1993,75 (6):1215-25.
[4] 刘晓茹,崔娴维.胃癌DNA错位修复基因hMSH2突变研究[J].解放军医学杂志,2000,25(2):125-6.Liu XR,Cui XW.Studies on DNA mismatch repair gene hMSH2 in gastric cancer[J].MedJChin PLA,2000,25(2):125-6.
[5] 马琳,张军航,鼓芝兰,等.错位修复基因hMSH2蛋白在人卵巢恶性肿瘤组织中的表达及其临床意义[J].中华妇产科杂志,2000,35(5):291-3.Ma L,ZhangJH,Gu LZ,et al.Expression of mismatch repair gene hMSH2 in human malignnt ovarian tumors and its clinical significance[J].ChinJObstet Gynecol,2000,35(5):291-3.
[6] 王立东,郑树.河南食管癌高发区人群食管和贲门癌变机制[J].郑州大学学报(医学版),2002,37(6):717-29.Wang LD,Zheng S.Cancerizationai mechanism of esophageal and cardia carcinoma in the high-occurrence region [J].JZhengzhou Univ (Med Sci),2002,37(6):717-29.
[7] 王立东,高文俊,杨万才,等.林州市人民医院9年食管、贲门癌3933例分析[J].河南医科大学学报,1997,32(1):9-12.Wang LD,Gao WJ,Yang WC,et al.Analysis of 3933 case esophageal or cardin carcinoma in nine years of Linzhou People’s Hospital[J].JHenan Med Coll,1997,32(1):9-12.
[8] 沈肖曹,史时芳,谢立平.人类错配修复基因系统与肿瘤[J].国外医学·泌尿系统分册(ForeignMed Sci·UrolNephrol Sect),2001,21(Suppl):10-2.
[9] Fink D,Aebi S,Howell SB,et al.The role of DNA mismatch repair in drug resistance[J].Clin Cancer Res,1998,4(1):1-6.
[10] Ouyang H,Shiwaku Y,Hagiwara H,et al.The insulin-like growth factor receptor gene os mutated in genetically unstable cancers of the endometrium stomach and colorectum [J].Cancer Res,1997,57(10):1851-4.
[11] 黄少明,郑镇木,吴晓翔,等.胸段食管癌外科治疗326例报告[J].第一军医大学学报,2002,22(10):949-50.Huang SM,Zheng ZM,Wu XX,et al.Surgical treatment of thoracic esophageal carcinoma:report of 326 cases[J].JFirst Mil Med Univ/Di YiJun Yi Da Xue Xue Bao,2002,22(10):949-50.
[12] 宋维舒.放疗后化疗治疗食管癌96例疗效观察[J].第一军医大学学报,2001,21(9):703-5.Song WS.Analysis of 96 case esophageal cancer with chemical therapy at,er radiative therapy[J].JFirst Mil Med Univ/Di YiJun Yi Da Xue Xue Bao,2001,21(9):703-5.
[13] Maruyama A,Saito T,Hachitanda Y,et al.Cancer history and loss of MSH2 and MLH1 protein expression in patients with endometrial hyperplasia[J].IntJGynecol Cancer,2003,13(3):352-60.
[14] Wang Y,Friedl W,Lamberti C,et al.Hereditary nonpolyposis colorectal caacer:frequent occurrence of large genomic deletions in MSH2 and MLH-1 genes[J].IntJCancer,2003,103(5):636-41.
[15] Rass K,Gutwein P,Welter C,et al.DNA mismatch repair enzyme hMSH2 in malignant melanoma:increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines[J].HistochemJ,2001,33(8):459-67.
[16] 李华川,赵新吉,刘海玲,等.食管癌和贲门癌组织中错配修复基因表达的研究[J].肿瘤杂志,2002,22(1):23-5.Li HC,Zhao XJ,Liu HL,et al.Studies of expression of mismatch repair gene in esophageal and cardia carcinoma tissues[J].JCancer,2002,22(1):23-5.
[17] 张钦宪,杜鹏,乐晓平,等.胃癌组织错配修复基因hMSH2 mRNA 的表达[J].河南医科大学学报,2001,36(4):379-82.Zhang QX,Du P,Le XP,et al.Expression of mismatch repair gene hMSH2 mRNA in gastric cancer tissues [J].JHenan Med Coll,2001,36(4):379-82.
[18] 李佩玲,刘梅梅,倪江.错配修复基因hMSH2研究的新进展[J].国外医学·遗传学分册(ForeignMed Sci·Genet Sect),2002,25(4):224-7.